Cachexia and drugs of ingredients of aprepitant (a real world drug study)
Summary:
Cachexia is found among people who take drugs with ingredients of aprepitant, especially for people who are male, 60+ old , have been taking the drugs for < 1 month. This phase IV clinical study is created by eHealthMe based on reports of 20,492 people who have side effects when taking drugs with ingredients of aprepitant from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Aponvie, Aprepitant, Cinvanti, Emend.
20,492 people reported to have side effects when taking drugs with ingredients of aprepitant.
Among them, 11 people (0.05%) have Cachexia
What is Cachexia?
Cachexia (loss of weight) is found to be associated with 660 drugs and 1,202 conditions by eHealthMe. Check the latest studies of Cachexia.
Number of reports submitted per year:

Time on drugs with ingredients of aprepitant when people have Cachexia *:
- < 1 month: 50 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 50 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Cachexia when taking drugs with ingredients of aprepitant *:
- female: 30 %
- male: 70 %
Age of people who have Cachexia when taking drugs with ingredients of aprepitant *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 20 %
- 40-49: 0.0 %
- 50-59: 10 %
- 60+: 70 %
Conditions people have *:
You may use this to check any potential undetected conditions.
- Neoplasm Malignant (cancer tumour): 2 people, 18.18%
- Nausea And Vomiting: 2 people, 18.18%
- Metastases To Liver (cancer spreads to liver): 2 people, 18.18%
- Pain: 2 people, 18.18%
- Type 1 Diabetes: 1 person, 9.09%
- Insomnia (sleeplessness): 1 person, 9.09%
- Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 1 person, 9.09%
- Colon Cancer: 1 person, 9.09%
- Gastric Cancer (stomach cancer): 1 person, 9.09%
- Gingival Cancer (cancer of gums): 1 person, 9.09%
Other drugs people take *:
You may use this to check any potential interacting drugs.
- Aloxi: 4 people, 36.36%
- Decadron: 4 people, 36.36%
- Avastin: 4 people, 36.36%
- Oxaliplatin: 3 people, 27.27%
- Fluorouracil: 3 people, 27.27%
- Gemcitabine: 3 people, 27.27%
- Neulasta: 2 people, 18.18%
- Magnesium Sulfate: 2 people, 18.18%
- Fosaprepitant: 2 people, 18.18%
- Zofran: 2 people, 18.18%
Other side effects people have besides Cachexia *:
You may use this to check any potential undetected side effects.
- Diarrhea: 5 people, 45.45%
- Dehydration (dryness resulting from the removal of water): 5 people, 45.45%
- Nausea And Vomiting: 5 people, 45.45%
- Fatigue (feeling of tiredness): 4 people, 36.36%
- Weakness: 4 people, 36.36%
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 36.36%
- General Physical Health Deterioration (weak health status): 3 people, 27.27%
- Ascites (accumulation of fluid in the abdominal cavity): 3 people, 27.27%
- Pain: 3 people, 27.27%
- Death: 3 people, 27.27%
* Approximation only. Some reports may have incomplete information.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Drugs with ingredients of aprepitant, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on aprepitant. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Breo Ellipta and Arthritis - Rheumatoid for Women aged 60+ - now
- Breo Ellipta and Rheumatoid Arthritis for Women aged 60+ - a second ago
- Lymphocyte Count Decreased and drugs of ingredients of carboplatin - 18 seconds ago
- Drug interactions of Promethazine Dm and Hydrochlorothiazide - 21 seconds ago
- Could Qvar Redihaler cause Hypersensitivity? - 26 seconds ago
- Strattera and Loss Of Consciousness for Women aged 20-29 - 36 seconds ago
- Drug interactions of Atarax and Monopril - 41 seconds ago
- Could Naproxen cause Metastases To Meninges? - 44 seconds ago
- Drug interactions of Lactobacillus Reuteri and Zantac - 44 seconds ago
- Could Clarithromycin cause Pancreatitis Acute? - 48 seconds ago